Vimarsana
Biggest News Aggregation in the World

Ensitex System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ensitex System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ensitex System Today - Breaking & Trending Today

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms - Vimarsana News

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

Abbott is integrating it’s EnSite X mapping system with Stereotaxis’s robotic surgical system

Stereotaxis, Inc.: Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms - Vimarsana News

Stereotaxis, Inc.: Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms - Vimarsana News

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

19.05.2023 - ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) - Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination ...

FDA Clears New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms - Vimarsana News

FDA Clears New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms

EnSite X EP mapping system with EnSite Omnipolar Technology provides a 360-degree view of the heart, regardless of catheter orientation

ABBOTT RECEIVES U.S. FDA CLEARANCE FOR NEW CARDIAC MAPPING SYSTEM TO IMPROVE HOW DOCTORS TREAT ABNORMAL HEART RHYTHMS - Vimarsana News

ABBOTT RECEIVES U.S. FDA CLEARANCE FOR NEW CARDIAC MAPPING SYSTEM TO IMPROVE HOW DOCTORS TREAT ABNORMAL HEART RHYTHMS

Abbott (NYSE: ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform available in the U.S. and across Europe that is designed to help physicians better treat abnormal heart rhythms ...